Press Releases about Beam Therapeutics Inc![]() From Beam Therapeutics
Via GlobeNewswire
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
MarketBeat Week in Review – 3/4 – 3/8
March 09, 2024
Via MarketBeat
![]() ![]() From Beam Therapeutics
Via GlobeNewswire
![]() ![]()
Is CRISPR Therapeutics the NVIDIA of gene editing?
February 26, 2024
Via MarketBeat
Topics
Artificial Intelligence
![]()
Analysts see over 50% gains in these 2 mid-cap biotech stocks
February 14, 2024
Via MarketBeat
Topics
Artificial Intelligence
![]() ![]() ![]() ![]() From Beam Therapeutics
Via GlobeNewswire
![]() ![]()
Beam Therapeutics Appoints Biotech Executive Christi Shaw to its Board of Directors
December 14, 2023
From Beam Therapeutics
Via GlobeNewswire
![]() ![]() From Beam Therapeutics
Via GlobeNewswire
![]() ![]() ![]() ![]() ![]() ![]() From Beam Therapeutics
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|
Penticton Herald
Phone number: 250-492-4002
E-mail: csr@ok.bc.ca
Address: 186 Nanaimo Ave. W.
Penticton, BC V2A 1N4
© Copyright 2015, Penticton Herald, Penticton, BC. Powered by BLOX Content Management System from TownNews.com.